GGrantIndex
← Leaderboards

Research Inst Of Fox Chase Can Ctr

Philadelphia, PA

Compare ↔
$416,348,524
Total funding
422
Grants

Funding over time

peak $36.8M · FY2006–25
$50M$37.5M$25M$12.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$415,789,795 · 420
AHRQ$558,729 · 2

By mechanism

R01$247,350,225 · 137
R21$25,491,848 · 58
P30$23,590,960 · 73
P01$21,616,755 · 23
R35$15,427,999 · 6
N01$11,543,208 · 4

Investigators at Research Inst Of Fox Chase Can Ctr

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Lu Chen$1,649,2521 gr2Israel Canadas$1,299,3581 gr3Yu Liu$940,0001 gr4Joseph Nicholas Bodor$483,3951 gr5Jaye C Gardiner$249,0001 gr6Paul Michael Campbell$188,0001 gr7Elizabeth Handorf$100,0001 gr8Samuel Gathere$10,0001 gr

Emerging Leaders

6–10 yrs in

1James Stuart Duncan$3,237,6262 gr2Yanis Boumber$2,133,6682 gr3Petr B. Makhov$1,568,2315 gr4Marshall Kerr Tulloch-Reid$1,221,4051 gr5Margret B Einarson$636,4681 gr6Philip Abbosh$437,8281 gr7Namrata Vijayvergia$306,7312 gr8Efrat Dotan$229,8221 gr

All-Time

Most funded here, all years

1David L Wiest$16,605,47018 gr2Siddharth Balachandran$16,088,06013 gr3Erica A Golemis$10,563,63311 gr4Neil Johnson$9,103,2845 gr5Vasily M Studitsky$6,950,1024 gr6John Karanicolas$5,760,9404 gr7Johnathan R. Whetstine$5,273,9432 gr8Jennifer Barsky Reese$4,849,6585 gr

Largest grants

Comprehensive Cancer Center Program at Fox Chase$4,014,812
P30 · FY2014 · CA
Comprehensive Cancer Center Program at Fox Chase$3,797,655
P30 · FY2013 · CA
Comprehensive Cancer Center Program at Fox Chase$3,105,436
P30 · FY2020 · CA
Comprehensive Cancer Center Program at Fox Chase$2,905,436
P30 · FY2019 · CA
New tools for understanding metastasis through tissue resident cells: enabling an Extensive Medicine strategy for metastatic disease$2,805,000
DP2 · FY2020 · CA
Comprehensive Cancer Center Program at Fox Chase$2,784,348
P30 · FY2025 · CA
Comprehensive Cancer Center Program at Fox Chase$2,763,834
P30 · FY2017 · CA
Comprehensive Cancer Center Program at Fox Chase$2,758,277
P30 · FY2018 · CA
Comprehensive Cancer Center Program at Fox Chase$2,675,570
P30 · FY2016 · CA
Molecular Basis for γδ T Lineage Specification$2,444,294
P01 · FY2025 · AI
Molecular basis of γδ T lineage specification$2,144,459
P01 · FY2019 · AI
FCCC-PENN SPORE in Ovarian Cancer$2,130,912
P50 · FY2013 · CA
Molecular basis of T lineage specification$2,019,751
P01 · FY2020 · AI
Immune Mechanisms That Control Ectromelia Virus Infection$2,014,562
U19 · FY2010 · AI
Molecular basis of γδ T lineage specification$2,004,349
P01 · FY2021 · AI
Immune Mechanisms That Control Ectromelia Virus Infection$1,990,501
U19 · FY2011 · AI
Molecular basis of γδ T lineage specification$1,980,932
P01 · FY2023 · AI
Comprehensive Cancer Center Program at Fox Chase$1,969,906
P30 · FY2015 · CA
Molecular basis of γδ T lineage specification$1,967,737
P01 · FY2022 · AI
Immune Mechanisms That Control Ectromelia Virus Infection$1,935,772
U19 · FY2009 · AI